These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37424466)

  • 1. Share of and Absolute Costs of Informal Care in Five Subpopulations of Outpatients with Dementia in Croatia: A Latent Profile Analysis.
    Sušac J; Vukojević J; Debogović S; Bajić Ž; Savić A; Đuran N; Hanževački M; Vitezić D; Mimica N
    J Alzheimers Dis; 2023; 94(4):1417-1430. PubMed ID: 37424466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in resource use and costs of dementia care between European countries: baseline data from the ICTUS study.
    Gustavsson A; Jonsson L; Rapp T; Reynish E; Ousset PJ; Andrieu S; Cantet C; Winblad B; Vellas B; Wimo A;
    J Nutr Health Aging; 2010 Oct; 14(8):648-54. PubMed ID: 20922341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS.
    Reed C; Belger M; Scott Andrews J; Tockhorn-Heidenreich A; Jones RW; Wimo A; Dodel R; Haro JM
    Int Psychogeriatr; 2020 Feb; 32(2):267-277. PubMed ID: 31134870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Analysis of Formal Care, Informal Care, and Productivity Losses in Primary Care Patients who Screened Positive for Dementia in Germany.
    Michalowsky B; Thyrian JR; Eichler T; Hertel J; Wucherer D; Flessa S; Hoffmann W
    J Alzheimers Dis; 2016; 50(1):47-59. PubMed ID: 26639964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and Resource Use Associated with Alzheimer's Disease in Italy: Results from an Observational Study.
    Bruno G; Mancini M; Bruti G; Dell'Agnello G; Reed C
    J Prev Alzheimers Dis; 2018; 5(1):55-64. PubMed ID: 29405234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settings.
    Reese JP; Hessmann P; Seeberg G; Henkel D; Hirzmann P; Rieke J; Baum E; Dannhoff F; Müller MJ; Jessen F; Geldsetzer MB; Dodel R
    J Alzheimers Dis; 2011; 27(4):723-36. PubMed ID: 21876256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1.
    Robinson RL; Rentz DM; Andrews JS; Zagar A; Kim Y; Bruemmer V; Schwartz RL; Ye W; Fillit HM
    J Alzheimers Dis; 2020; 75(2):437-450. PubMed ID: 32250304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study.
    Nakanishi M; Igarashi A; Ueda K; Brnabic AJM; Treuer T; Sato M; Kahle-Wrobleski K; Meguro K; Yamada M; Mimura M; Arai H
    J Alzheimers Dis; 2020; 74(1):127-138. PubMed ID: 31985460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of care in a mild-to-moderate Alzheimer clinical trial sample: key resources and their determinants.
    Gustavsson A; Cattelin F; Jönsson L
    Alzheimers Dement; 2011 Jul; 7(4):466-73. PubMed ID: 21784355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caregivers' Sense of Coherence: Implications on Direct and Indirect Costs of Dementia Care.
    Turró-Garriga O; Viñas-Díez V; Conde-Sala JL; Calvó-Perxas L; Cullell-Juncà M; Mas-Vall-Llosera G; Flaqué M; Turon-Estrada A; Juvinyà-Canal D; Mioshi E; Garre-Olmo J
    J Alzheimers Dis; 2020; 78(1):117-126. PubMed ID: 32925037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care.
    Behrens S; Rattinger GB; Schwartz S; Matyi J; Sanders C; DeBerard MS; Lyketsos CG; Tschanz JT
    Int Psychogeriatr; 2018 Oct; 30(10):1499-1507. PubMed ID: 29559029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct and indirect costs and resource use in dementia care: A cross-sectional study in patients living at home.
    Farré M; Haro JM; Kostov B; Alvira C; Risco E; Miguel S; Cabrera E; Zabalegui A
    Int J Nurs Stud; 2016 Mar; 55():39-49. PubMed ID: 26632506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of costs of care for patients with Alzheimer's disease.
    Jönsson L; Eriksdotter Jönhagen M; Kilander L; Soininen H; Hallikainen M; Waldemar G; Nygaard H; Andreasen N; Winblad B; Wimo A
    Int J Geriatr Psychiatry; 2006 May; 21(5):449-59. PubMed ID: 16676288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study.
    Lenox-Smith A; Reed C; Lebrec J; Belger M; Jones RW
    BMC Geriatr; 2016 Nov; 16(1):195. PubMed ID: 27887645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informal costs of dementia care: estimates from the National Longitudinal Caregiver Study.
    Moore MJ; Zhu CW; Clipp EC
    J Gerontol B Psychol Sci Soc Sci; 2001 Jul; 56(4):S219-28. PubMed ID: 11445614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Health-Related Quality of Life in Informal Caregivers of Dementia Patients in Zagreb, Croatia, a Cross Sectional Study.
    Lucijanić J; Baždarić K; Lucijanić M; Maleković H; Hanževački M; Jureša V
    Psychiatr Danub; 2021 Dec; 33(Suppl 13):189-198. PubMed ID: 35150485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare utilization and costs in primary care patients with dementia: baseline results of the DelpHi-trial.
    Michalowsky B; Flessa S; Eichler T; Hertel J; Dreier A; Zwingmann I; Wucherer D; Rau H; Thyrian JR; Hoffmann W
    Eur J Health Econ; 2018 Jan; 19(1):87-102. PubMed ID: 28160100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs of care for people with dementia just before and after nursing home placement: primary data from eight European countries.
    Wübker A; Zwakhalen SM; Challis D; Suhonen R; Karlsson S; Zabalegui A; Soto M; Saks K; Sauerland D
    Eur J Health Econ; 2015 Sep; 16(7):689-707. PubMed ID: 25069577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of Care of Agitation Associated With Dementia in 8 European Countries: Results From the RightTimePlaceCare Study.
    Costa N; Wübker A; De Mauléon A; Zwakhalen SMG; Challis D; Leino-Kilpi H; Hallberg IR; Stephan A; Zabalegui A; Saks K; Molinier L; Wimo A; Vellas B; Sauerland D; Binot I; Soto ME;
    J Am Med Dir Assoc; 2018 Jan; 19(1):95.e1-95.e10. PubMed ID: 29275939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between global severity of patients with Alzheimer's disease and costs of care in Spain; results from the co-dependence study in Spain.
    Darbà J; Kaskens L; Lacey L
    Eur J Health Econ; 2015 Nov; 16(8):895-905. PubMed ID: 25348897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.